Biscayne Pharmaceuticals, Inc. is a privately held biopharmaceutical company discovering and developing novel therapies based on growth hormone-releasing hormone (GHRH) analogs. The company’s technology stems from the discoveries of Dr. Andrew V. Schally, a Nobel laureate and pioneering endocrine drug developer. Our core technology is a platform of synthetic peptides based on one of the key brain hormones that regulates growth, Growth Hormone-Releasing Hormone (GHRH), which we believe has clinical applicability for cancer, cardiac disease, Alzheimer’s disease, diabetes, wound healing and other diseases. It represents an entirely new paradigm of therapy.
View Top Employees from Biscayne Pharmaceuticals, Inc.| Website | https://www.biscaynepharma.com |
| Revenue | $1 million |
| Funding | $1.6 million |
| Employees | 4 (0 on RocketReach) |
| Founded | 2012 |
| Address | 4770 Biscayne Blvd, Miami, Florida 33137, US |
| Phone | (786) 502-4220 |
| Fax | (305) 468-6352 |
| Technologies |
JavaScript,
HTML,
PHP
+9 more
(view full list)
|
| Industry | Pharmaceuticals, Manufacturing General, Biotechnology, Manufacturing, Science and Engineering, Pharmaceutical, Health Care, Therapeutics |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular Biscayne Pharmaceuticals, Inc. employee's phone or email?
Biscayne Pharmaceuticals, Inc. Questions
The Biscayne Pharmaceuticals, Inc. annual revenue was $1 million in 2024.
Biscayne Pharmaceuticals, Inc. is based in Miami, Florida.
The NAICS codes for Biscayne Pharmaceuticals, Inc. are [32, 3254, 32541, 325].
The SIC codes for Biscayne Pharmaceuticals, Inc. are [283, 28].
Related Companies
